Results 111 to 120 of about 15,436 (169)

Patient Perspectives on Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Attributes. [PDF]

Cardiol Ther
Kumar N, Coulter J, Haddad-Angulo A, Baig L, Chung H, Chandrasekar SM, Vass C, Galinsky J, Carr AM, McIntosh K, Hauber B.   +10 more
europepmc   +1 more source

Social Determinants of Health and Outcomes in Transthyretin Amyloid Cardiomyopathy. [PDF]

Am J Cardiol
Mallepally A, Patel A, Slivnick J, Shah KB, Trankle CR.   +4 more
europepmc   +1 more source

The Burden of Transthyretin Amyloid Cardiomyopathy on Caregivers and Patients in Japan: A Cross‑Sectional Real‑World Survey. [PDF]

Adv Ther
Kitaoka H, Enami M, Kamei K, Hamada J, Khanji C, Garratt-Wheeldon J, Wright J, Yuasa A.   +7 more
europepmc   +1 more source

Baroreflex Activation Therapy in a Patient With Transthyretin Amyloid Cardiomyopathy. [PDF]

JACC Case Rep
Khanna NR, DenDulk A, Atteya G, Talati SN.   +3 more
europepmc   +1 more source

Differential Effects of Tafamidis on Cardiac Remodelling in Transthyretin Amyloid Cardiomyopathy: Evidence From Contemporary Imaging Data. [PDF]

Eur J Clin Invest
Quader T, Patel K, Sindone J, Khanna S, Bhat A, Chen H, Gan G, Nerlekar N, Eshoo S, Bart N, Thomas L, Sindone A.   +11 more
europepmc   +1 more source

Causal Inference Challenges in Evaluating Baroreflex Activation Therapy for Transthyretin Amyloid Cardiomyopathy: A Critical Appraisal. [PDF]

JACC Case Rep
Humayun SH, Bareeqa SB.
europepmc   +1 more source

Survival in a Contemporary, Real-World, Matched Cohort of Patients with Transthyretin Amyloid Cardiomyopathy Treated vs Not Treated with Tafamidis. [PDF]

Cardiol Ther
Aus dem Siepen F, Dispenzieri A, Hanna M, Carlsson M, Garcia-Pavia P.   +4 more
europepmc   +1 more source

Efficacy and Safety of Acoramidis in Japanese Adults With Symptomatic Transthyretin Amyloid Cardiomyopathy. [PDF]

Circ Rep
Endo J, Tsujita K, Izumi C, Yano T, Kitaoka H, Sekijima Y, Tahara N, Ishii S, Okumura T, Hashimoto T, Fukata M, Minamino T, Raizner A, Chen Y, Otsuka Y, Mercuri MF, Minamisawa M, Ando Y.   +17 more
europepmc   +1 more source

Coexistence of hereditary transthyretin amyloid cardiomyopathy and sarcomeric hypertrophic cardiomyopathy: a multimodality imaging and genetic case report. [PDF]

Eur Heart J Case Rep
Negri F, Driussi M, Puppato M, Zuliani L, Imazio M.   +4 more
europepmc   +1 more source

Patient Characteristics and Diagnosis of Transthyretin Amyloid Cardiomyopathy in Japan: Baseline Analysis of J-COSSA. [PDF]

JACC Asia
Endo J, Tanzawa K, Sato Y, Watanabe H, Takashio S, Kubo T, Minamisawa M, Tanaka H, Hashimoto T, Kawano H, Sakata K, Kanamori H, Tsuruda T, Fukata M, Kitagawa T, Noma T, Okada A, Kitai T, Yajima A, Iwataki M, Kondo H, Yamada Y, Ishii S, Izumiya Y, Ieda M, Kuwahara K, Nakamura K, Tahara N, Ueda M, Sekijima Y, Naiki H, Tsujita K, Kitaoka H, Inomata T.   +33 more
europepmc   +1 more source